Drug recall
Questran Powder (Cholestyramine for Oral Suspension, USP) 4 grams cholestyramine resin, USP per scoopful, 378…
FDA recall event 27751 · Class III · Bristol-Myers Squibb Company
Key facts
| Event ID | 27751 |
|---|---|
| Recall numbers | D-123-4 |
| Recalling firm | Bristol-Myers Squibb Company |
| Product type | Drugs |
| Products | Questran Powder (Cholestyramine for Oral Suspension, USP) 4 grams cholestyramine resin, USP per scoopful, 378 G (168 G anhydrous cholestyramine) Cans, Rx Only, Mfd by: Bristol-Myers Squibb Co… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Superpotent (6 month stability) |
| Initiation date | Nov 14, 2003 |
| City | New Brunswick |
| Country | United States |
| FEI number | 2211101 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports